SEARCH
Quotes News NAV
Mid-Session  Detailed News Markets  >  Equity  >  Detailed News
Market behaviour during the course of the trading session for last one week.
Your Result on : Equity   |  News | Mid-Session | Detailed News
Back
Sensex jumps 51 pts, Nifty trades above 25,450; VIX slumps 3.54%
08-Jul-25   13:32 Hrs IST

The key equity indices traded near the flatline with some positive points in the afternoon trade. IT, Realty and private bank shares advanced while consumer durables, media and pharma shares declined. The Nifty traded above 25,450 mark.

At 13:28 IST, the barometer index, the S&P BSE Sensex advanced 51.36 points or 0.06% to 83,495.54. The Nifty 50 index rose 4.75 points or 0.02% to 25,466.95.

The broader market underperformed the frontline indices. The S&P BSE Mid-Cap index shed 0.15% and the S&P BSE Small-Cap index fell 0.44%.

The market breadth was negative. On the BSE, 1,669 shares rose and 2,232 shares fell. A total of 176 shares were unchanged.

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, tanked 3.54% to 12.12.

Gainers & Losers:

Kotak Mahindra Bank (up 3.30%), Grasim Industries (up 1.83%), Eternal (up 1.61%), UltraTech Cement (up 1.13%) and Asian Paints (up 1.04%) were the major Nifty50 gainers.

Titan Company (down 5.38%), Dr Reddy's Laboratories (down 2.21%), Trent (down 1.76%), Bajaj Auto (down 1.64%) and Cipla (down 1.48%) were the major Nifty50 Losers.

Kotak Mahindra Bank rose 3.30% after the bank's average total deposits jumped 12.9% to Rs 4,91,998 crore as of 30th June 2025 compared with Rs 4,35,603 crore as of 30th June 2024. Average CASA increased 4.2% to Rs 1,91,995 crore as of 30th June 2025 as against 1,84,306 crore as of 30th June 2024.

Titan Company tanked 5.368%. The company reported a decent performance in Q1 FY26, with its domestic jewellery business growing 18% year-on-year despite challenges from gold price volatility.

Stocks in Spotlight:

Mahindra & Mahindra (M&M) shed 0.73%. The company said that its total production jumped 20.15% to 83,435 units in the month of June 2025, compared with 69,441 units produced in the same period last year.

Ceinsys Tech rallied 1.45% after the company received a letter of award (LoA) worth Rs 114.99 crore from the Mumbai Metropolitan Region Development Authority (MMRDA).

Tata Motors rose 0.30%. The company said that Jaguar Land Rover's wholesale volumes for Q1 FY26 were 87,286 units (excluding the Chery Jaguar Land Rover China JV), down 10.7% compared with Q1 FY25.

P N Gadgil Jewellers fell 1.21%. The company reported a 2.77% year-on-year (YoY) increase in total revenue to Rs 1,713.7 crore for the first quarter of FY26, up from Rs 1,667.5 crore in the same period last year.

Global Markets:

Most European markets opened higher on Tuesday amid a recent tariff update from US President Donald Trump, as investors looked ahead to further development on trade deals.

Asian markets traded mixed, brushing off fresh tariff threats from US President Donald Trump. Trump, in a series of posts on Truth Social, announced steep new duties on goods from 14 countries, including key Asia-Pacific partners.

Starting August 1, exports to the US from Japan, South Korea, Malaysia, Kazakhstan, and Tunisia will face 25% tariffs. Indonesia is set to be hit with a 32% excise duty, while Bangladesh, Cambodia, and Thailand will see 35% to 36% rates. Imports from Laos and Myanmar will be subject to a 40% duty.

Despite the tariff escalation, risk appetite remained firm across Asian bourses, though Wall Street reflected a more cautious tone overnight.

US stocks pulled back from record highs on Monday, pressured by profit-taking and increased risk aversion in the tech sector. The S&P 500 fell 0.8%, the Nasdaq Composite dropped 0.9%, and the Dow Jones Industrial Average also slid 0.9%.

Tesla shares plunged, wiping out $68 billion in market capitalization, after CEO Elon Musk announced plans to launch a new political party. The move sparked concerns over further distractions from his leadership at the EV giant.

In positive corporate news, Kalvista Pharmaceuticals rallied after the FDA approved its on-demand oral treatment for hereditary angioedema, marking the first of its kind in the US market.

Looking ahead, investors are awaiting the minutes of the Federal Reserve's June policy meeting, scheduled for release Wednesday.

Powered by Capital Market - Live News